Glucoreg Liquid
NDC Package 43742-2064-1
Package Information
Glucoreg (ascorbicum acidum, pyridoxinum hydrochloricum, riboflavinum, sarcolacticum acidum, thiaminum hydrochloricum, dhea (dehydroepiandrosterone), adenosinum triphosphoricum dinatrum, alpha-lipoicum acidum, citricum acidum, fumaricum acidum, nadidum, pantothenic acid, acetaldehyde, insulinum (suis), insulinum (human), hepar suis, pancreas suis, phloridzinum, alloxanum, berberis vulgaris, carcinosin, lycopodium clavatum, momordica balsamina, phosphoricum acidum, phosphorus, syzygium jambolanum,) liquids is for temporary relief of symptoms related to high blood sugar including dry mouth, thirst, night sweats, sugar and carb cravings.****These statements are based upon homeopathic principles. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-2064.
Identification & Billing
Clinical Specifications
- ASCORBIC ACID 8 [hp_X]/mL
- PYRIDOXINE HYDROCHLORIDE 8 [hp_X]/mL
- RIBOFLAVIN 6 [hp_C]/mL
- LACTIC ACID, L- 8 [hp_X]/mL
- THIAMINE HYDROCHLORIDE 6 [hp_X]/mL
- PRASTERONE 32 [hp_C]/mL
- ADENOSINE TRIPHOSPHATE DISODIUM 6 [hp_C]/mL
- THIOCTIC ACID 8 [hp_X]/mL
- ANHYDROUS CITRIC ACID 30 [hp_C]/mL
- FUMARIC ACID 6 [hp_C]/mL
- NADIDE 12 [hp_C]/mL
- PANTOTHENIC ACID 8 [hp_X]/mL
- ACETALDEHYDE 6 [hp_X]/mL
- INSULIN PORK 6 [hp_C]/mL
- INSULIN HUMAN 6 [hp_C]/mL
- PORK LIVER 8 [hp_X]/mL
- SUS SCROFA PANCREAS 8 [hp_X]/mL
- PHLORIZIN 16 [hp_X]/mL
- ALLOXAN 6 [hp_C]/mL
- BERBERIS VULGARIS ROOT BARK 6 [hp_C]/mL
- HUMAN BREAST TUMOR CELL 10 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 6 [hp_X]/mL
- MOMORDICA BALSAMINA IMMATURE FRUIT 6 [hp_X]/mL
- PHOSPHORIC ACID 6 [hp_X]/mL
- PHOSPHORUS 30 [hp_C]/mL
- SYZYGIUM CUMINI SEED 10 [hp_X]/mL
- SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS 6 [hp_C]/mL
- GYMNEMA SYLVESTRE LEAF 6 [hp_X]/mL
- TRIGONELLA FOENUM-GRAECUM WHOLE 8 [hp_X]/mL
- BARIUM OXALOSUCCINATE 32 [hp_C]/mL
- Acidifying Activity - [MoA] (Mechanism of Action)
- Analogs/Derivatives - [Chemical/Ingredient]
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Ascorbic Acid - [CS]
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Insulin - [CS]
- Insulin - [EPC] (Established Pharmacologic Class)
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 43742 - Deseret Biologicals, Inc.
- 43742-2064 - Glucoreg
- 43742-2064-1 - 30 mL in 1 BOTTLE, DROPPER
- 43742-2064 - Glucoreg
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43742-2064-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Glucoreg, a human over the counter drug labeled by Deseret Biologicals, Inc.. This liquid is formulated for oral use and contains ascorbic acid; pyridoxine hydrochloride; riboflavin; lactic acid, l-; thiamine hydrochloride; prasterone; adenosine triphosphate disodium; thioctic acid; anhydrous citric acid; fumaric acid; nadide; pantothenic acid; acetaldehyde; insulin pork; insulin human; pork liver; sus scrofa pancreas; phlorizin; alloxan; berberis vulgaris root bark; human breast tumor cell; lycopodium clavatum spore; momordica balsamina immature fruit; phosphoric acid; phosphorus; syzygium cumini seed; salmonella enterica subsp. enterica serovar enteritidis; gymnema sylvestre leaf; trigonella foenum-graecum whole; barium oxalosuccinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on December 07, 2022. The current certification is valid through December 31, 2026.
How is this Deseret Biologicals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742206401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.